Eiger Biopharmaceuticals Price on March 21, 2024

EIGRDelisted Stock  USD 0.74  0.03  3.90%   
If you're considering investing in Eiger Stock, it is important to understand the factors that can impact its price. As of today, the current price of Eiger Biopharmaceutica stands at 0.74, as last reported on the 23rd of November, with the highest price reaching 0.78 and the lowest price hitting 0.72 during the day. We have found twenty-four technical indicators for Eiger Biopharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Eiger Biopharmaceutica's Standard Deviation of 6.44, mean deviation of 4.39, and Variance of 41.42 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Eiger Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
EIGR
Based on monthly moving average Eiger Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eiger Biopharmaceutica by adding Eiger Biopharmaceutica to a well-diversified portfolio.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Eiger Biopharmaceutica Stock history

Eiger Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eiger is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eiger Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eiger Biopharmaceutica stock prices may prove useful in developing a viable investing in Eiger Biopharmaceutica
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California. Eiger Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.

Eiger Biopharmaceutica Stock Technical Analysis

Eiger Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Eiger Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eiger Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Eiger Biopharmaceutica Period Price Range

Low
November 23, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Eiger Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Eiger Biopharmaceutica November 23, 2024 Market Strength

Market strength indicators help investors to evaluate how Eiger Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eiger Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Eiger Biopharmaceutica stock market strength indicators, traders can identify Eiger Biopharmaceuticals entry and exit signals to maximize returns

Eiger Biopharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Eiger Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of Eiger Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eiger to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Eiger Stock

If you are still planning to invest in Eiger Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eiger Biopharmaceutica's history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals